Kezdőlap・Részvénylista・Humana Inc

Humana Inc

Lezárt

SzektorEgészségügy

386.84 0.59

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

380

Maximum

389.39

Fő mutatók
By Trading Economics
Bevétel	-491M 693M
Értékesítés	1.2B 41B
P/E Szektor átlag	36.353 57.002
Egy részvényre jutó nyereség	7.61
Osztalékhozam	0.92
Profit margin	1.696
Munkavállalók	67,060
EBITDA	-658M 1.3B

Ajánlások
By TipRanks
Ajánlások	Vétel
12 hónapos előrejelzés	+10.49% upside

Osztalékok
By Acuity
Osztalékhozam Szektor átlag	0.92% 2.22%
Következő eredményjelentés	2026. nov. 4.
Következő osztalékfizetési dátum	2026. okt. 30.
Következő korábbi osztalék dátum	2026. szept. 25.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	-427M 46B
Előző nyitás	386.25
Előző zárás	386.84

Hangulat hírek alapján

By Acuity

17%

83%

43 / 340 Rangsor szerint Healthcare

Humana Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 14. 19:46 UTC

Humana Inc shares are higher today, reflecting a broader positive market trend despite recent negative sentiment following a decline in U.S. retail sales.

2026. aug. 12. 20:01 UTC

Humana Inc shares are higher during Wednesday's session, continuing an upward trend since Tuesday. The move occurs amid mixed macroeconomic signals and geopolitical tensions.

2026. aug. 10. 19:16 UTC

News

Humana shares advance as JPMorgan raises price target to $393.

2026. aug. 7. 20:03 UTC

Humana Inc shares are higher today, continuing strong momentum from recent sessions. No specific company news was identified to explain this price action.

2026. aug. 6. 23:02 UTC

Humana Inc shares are lower in after-market trading, continuing a decline since Thursday's close and remaining below their 20-day moving average.

2026. aug. 5. 19:56 UTC

News

Social Media

Morgan Stanley upgraded Humana Inc to Equal-Weight and raised its price target to $370. Shares are gaining amid positive analyst sentiment and service area expansion.

2026. aug. 4. 20:04 UTC

News

Humana Inc is under investigation by Bronstein, Gewirtz & Grossman, LLC, raising concerns among investors and contributing to a decline in shares.

2026. aug. 3. 22:26 UTC

Humana Inc. shares are higher in after-market trading, continuing gains since Monday's close, though still below the 20-day moving average.

2026. júl. 31. 19:36 UTC

News

Humana Inc shares are lower today amid broader weakness in the Managed Health Care sector, despite price target increases from TD Cowen and Barclays.

2026. júl. 30. 18:36 UTC

News

Upgrades from Guggenheim, Evercore ISI boost Humana investor sentiment.

2026. júl. 29. 23:06 UTC

Humana Inc shares are trading lower in after-market hours, continuing a decline below the 20-day moving average and near the one-month trading range's lower end.

2026. júl. 28. 23:16 UTC

News

Social Media

Humana shares decline in after-market trading following the end of a Medicare drug subsidy program, which may raise costs for seniors and pressure insurers.

2026. júl. 27. 19:16 UTC

News

Humana Inc. shares are lower as Schubert Jonckheer & Kolbe LLP investigates potential false statements about healthcare costs amid ongoing securities fraud claims.

2026. júl. 24. 19:31 UTC

Humana Inc's shares are lower today amid broader weakness in the Managed Health Care sub-sector, reversing a trend of higher daily closes since Thursday.

2026. júl. 22. 19:26 UTC

Humana Inc. shares are lower today amid notable volatility and a mixed performance in global markets, with U.S. indices generally declining.

2026. júl. 20. 18:46 UTC

Humana Inc's shares are higher today, reflecting a slight increase since Friday's close. The stock is near the upper end of its one-month trading range.

Társak összehasonlítása

Árváltozás

Humana Inc Előrejelzés

Célár

By TipRanks

10.49% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 429.86 USD 10.49%

Magas 624 USD

Alacsony 280 USD

23 Wall Street elemző 12 hónapos célárain alapulva a(z)Humana Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

23 ratings

Vétel

Tartás

Eladás

23 Wall Street elemző célárain alapulva a(z)Humana Inc termékhez az elmúlt 3 hónapban.

Hangulat

By Acuity

43 / 340 Rangsor szerint Egészségügy

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk Humana Inc

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.